Current Assets
UnitedHealth Group·Balance Sheet Statement·14 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | $92B | $92.3B | $85.8B | $96.3B | $93.7B | $95.1B | $90.6B | $91.1B |
| Debt Securities Amortized Cost | $48.3B | $48.6B | $50.3B | $49.3B | $49.2B | $48.9B | $50.1B | $52.3B |
| Cash, Cash Equivalents, and Marketable Securities | $44.7B | $46.3B | $46.9B | $46.4B | $46.6B | $46.8B | $48.2B | $50.1B |
| Cash and cash equivalents | $26.3B | $32.4B | $25.3B | $30.7B | $28.6B | $27.2B | $24.4B | $28B |
| Accounts receivable, net | $23.1B | $20B | $22.4B | $26.9B | $24.1B | $22.7B | $23B | $26.6B |
| Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) | $26.8B | $27.5B | $26.1B | $26B | $28.6B | $32.8B | $29.7B | $24.6B |
| Other Receivables | $26.8B | $27.5B | $26.1B | $26B | $28.6B | $32.8B | $29.7B | $24.6B |
| Prepaid expenses and other current assets | $7.4B | $7.6B | $8.2B | $9B | $9B | $9B | $9.7B | $8.7B |
| Trading Securities in Marketable Securities | — | — | — | — | — | — | $3.3B | $3.5B |
| Available-for-Sale Debt Securities - Amortized Cost | $5.2B | $4.9B | — | $3.7B | $3.5B | $3.5B | — | $3.3B |
| Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year) | $5.2B | $4.9B | — | $3.7B | $3.5B | $3.5B | — | $3.3B |
| Trading assets | $5.1B | $4.9B | — | $3.7B | $3.5B | $3.5B | — | $3.3B |
| Short-term investments | $5B | $4.7B | $3.8B | $3.6B | $3.4B | $3.4B | $3.8B | $3.2B |
| Available-for-Sale Debt Securities - Fair Value (Maturing Within 1 Year) | $362M | $319M | — | $341M | $319M | $264M | — | $268M |